Share
Jose Pablo Morales
Veranex, the industry’s first Innovation CRO (iCRO) focused on redefining end-to-end MedTech development, has appointed Jose Pablo Morales, M.D., as Chief Medical Officer.
The appointment strengthens Veranex’s executive leadership team and reinforces its commitment to accelerating MedTech innovation responsibly while supporting clinical, regulatory, and commercial success for its clients.
Dr. Morales joins Veranex following a distinguished career at the U.S. Food and Drug Administration (FDA), where he provided clinical and regulatory oversight for more than 1,000 medical device submissions. His experience spans Premarket Approvals (PMAs), Investigational Device Exemptions (IDEs), and breakthrough device designations, giving him deep insight into regulatory pathways and evidence expectations. He also played a pivotal role in the implementation and adoption of the FDA’s Early Feasibility Studies (EFS) pathway, helping enable earlier and more efficient clinical evaluation of innovative technologies.
Most recently, Dr. Morales served as Senior Medical Advisor in the FDA’s Office of Clinical Policy, where he guided cross-center initiatives addressing complex clinical trials, ethical standards, and emerging regulatory challenges. His background combines hands-on clinical experience with regulatory leadership, particularly in cardiovascular and implantable device development, providing a unique perspective on translating innovation from concept to patient care.
As Chief Medical Officer, Dr. Morales will lead Veranex’s medical and clinical vision across its integrated services platform. His expertise will enhance the company’s capabilities in modern clinical trial design, real-world evidence generation, and digital innovation. His appointment builds on Veranex’s recent launch of the Innovation CRO model, designed to streamline MedTech R&D and commercialization in a capital-constrained environment, helping clients bring transformative technologies to market faster and more efficiently.
Related posts
.jpg "Integra LifeSciences Appoints Dr. Raymond Turner as Chief Medical Officer")
